Maxim Group Upgrades Virpax Pharmaceuticals, Inc. (VRPX) to Buy
Tweet Send to a Friend
Maxim Group analyst Naz Rahman upgraded Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
